Tagrid Jar-Allah , Karin Brandell , Frida Gyllenberg , Janina Kaislasuo , Helena Kopp-Kallner , Kristina Cederblad , Oskari Heikinheimo , Kristina Gemzell-Danielsson , Helena Hognert , On behalf of the VEMA (Very Early Medication Abortion) Study Group
{"title":"Change in hCG levels after very early medication abortion for pregnancy of unknown location or probable intrauterine pregnancy","authors":"Tagrid Jar-Allah , Karin Brandell , Frida Gyllenberg , Janina Kaislasuo , Helena Kopp-Kallner , Kristina Cederblad , Oskari Heikinheimo , Kristina Gemzell-Danielsson , Helena Hognert , On behalf of the VEMA (Very Early Medication Abortion) Study Group","doi":"10.1016/j.contraception.2025.110902","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective(s)</h3><div>To evaluate changes in serum/plasma human chorionic gonadotropin (hCG) from baseline levels in very early medication abortion (VEMA) in pregnancies of unknown location (PUL) and probable intrauterine pregnancy (IUP) to confirm treatment success.</div></div><div><h3>Study design</h3><div>A prospective cohort was selected from the VEMA randomized controlled trial conducted at 26 sites across nine countries. Patients with a gestational age ≤42 days without confirmed IUP on ultrasound (<em>n</em> = 741) received medication abortion according to WHO guidelines, hCG was measured at mifepristone intake and repeated on day 7 (+/-2). Changes in hCG were analyzed to distinguish the trends associated with complete abortion versus ectopic pregnancy, ongoing pregnancy, and incomplete abortion.</div></div><div><h3>Results</h3><div>Among 533 cases with complete abortion, a decline in hCG level of ≥80% was observed in 96.8 of cases 7 (+/-2) days post-abortion. The mean hCG decline for complete abortions was 94% (CI: 93.2–94.9). None of the ectopic pregnancies 8 (1.7%) or ongoing pregnancies 21 (2.9%), showed a decline of ≥80%. Rising or insufficient decline (<80%) indicated ectopic and ongoing pregnancy. The hCG trend following complete abortion was significantly different from all other outcomes (<em>p</em> < 0.001), but trends did not distinguish between ectopic, ongoing pregnancy, or incomplete abortion.</div></div><div><h3>Conclusion(s)</h3><div>A hCG decline of ≥80% within 7 (+/-2) days can effectively confirm complete abortion and rule out ectopic and ongoing pregnancies in early medication abortion. These results highlight the effectiveness of hCG monitoring as a reliable follow-up tool for managing VEMA without confirmed IUP.</div></div><div><h3>Implications</h3><div>This study highlights the value of hCG monitoring in early medication abortions in pregnancy of unknown location to differentiate between complete or incomplete abortion, ectopic, or ongoing pregnancy. An hCG decline of ≥80% within 7 (+/-2) days post-mifepristone can confirm complete abortion and help exclude ectopic and ongoing pregnancy.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"147 ","pages":"Article 110902"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0010782425000939","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective(s)
To evaluate changes in serum/plasma human chorionic gonadotropin (hCG) from baseline levels in very early medication abortion (VEMA) in pregnancies of unknown location (PUL) and probable intrauterine pregnancy (IUP) to confirm treatment success.
Study design
A prospective cohort was selected from the VEMA randomized controlled trial conducted at 26 sites across nine countries. Patients with a gestational age ≤42 days without confirmed IUP on ultrasound (n = 741) received medication abortion according to WHO guidelines, hCG was measured at mifepristone intake and repeated on day 7 (+/-2). Changes in hCG were analyzed to distinguish the trends associated with complete abortion versus ectopic pregnancy, ongoing pregnancy, and incomplete abortion.
Results
Among 533 cases with complete abortion, a decline in hCG level of ≥80% was observed in 96.8 of cases 7 (+/-2) days post-abortion. The mean hCG decline for complete abortions was 94% (CI: 93.2–94.9). None of the ectopic pregnancies 8 (1.7%) or ongoing pregnancies 21 (2.9%), showed a decline of ≥80%. Rising or insufficient decline (<80%) indicated ectopic and ongoing pregnancy. The hCG trend following complete abortion was significantly different from all other outcomes (p < 0.001), but trends did not distinguish between ectopic, ongoing pregnancy, or incomplete abortion.
Conclusion(s)
A hCG decline of ≥80% within 7 (+/-2) days can effectively confirm complete abortion and rule out ectopic and ongoing pregnancies in early medication abortion. These results highlight the effectiveness of hCG monitoring as a reliable follow-up tool for managing VEMA without confirmed IUP.
Implications
This study highlights the value of hCG monitoring in early medication abortions in pregnancy of unknown location to differentiate between complete or incomplete abortion, ectopic, or ongoing pregnancy. An hCG decline of ≥80% within 7 (+/-2) days post-mifepristone can confirm complete abortion and help exclude ectopic and ongoing pregnancy.
期刊介绍:
Contraception has an open access mirror journal Contraception: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
The journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.